找化学品上960化工网!
960化工网

坎地沙坦酯 | 145040-37-5

坎地沙坦酯
Candesartan cilexetil
145040-37-5
C33H34N6O6
610.6597
如需查看该化合物的详细结构式,mol文件,smile,InChi 请点击:坎地沙坦酯结构式
2540
坎地沙坦酯价格
简介
Candesartan Cilexetil (TCV-116)是血管紧张素II拮抗剂,可用于高血压。
名称和标识符
MDL MFCD00871371
InChIKey GHOSNRCGJFBJIB-UHFFFAOYSA-N
Inchi 1S/C33H34N6O6/c1-3-42-32-34-28-15-9-14-27(31(40)43-21(2)44-33(41)45-24-10-5-4-6-11-24)29(28)39(32)20-22-16-18-23(19-17-22)25-12-7-8-13-26(25)30-35-37-38-36-30/h7-9,12-19,21,24H,3-6,10-11,20H2,1-2H3,(H,35,36,37,38)
SMILES O(C(=O)OC([H])(C([H])([H])[H])OC(C1C([H])=C([H])C([H])=C2C=1N(C(=N2)OC([H])([H])C([H])([H])[H])C([H])([H])C1C([H])=C([H])C(C2=C([H])C([H])=C([H])C([H])=C2C2N=NN([H])N=2)=C([H])C=1[H])=O)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H]
别名信息
- 中文别名 -
  • 坎地沙坦酯
  • 2-乙氧基-1-[[2'-(1H-四氮唑-5-基)[1,1'-联苯基]-4-基]甲基]-1H-苯并咪唑-7-甲酸-1-[[(环己氧基)羰基]氧基]乙酯
  • 坎地沙坦西来替昔酯
  • 3,4-二甲基二苯甲酮
  • Candesartan Cilexetil 坎地沙坦酯
  • 坎地沙坦
  • 坎地沙坦酯 EP标准品
  • 坎地沙坦酯 标准品
  • 坎地沙坦酯(100mg)
  • 坎地沙坦酯峰鉴别 EP标准品
  • 坎地沙坦酯系统适用性 EP标准品
  • (±)-1-(环己氧代羰基氧代)乙基-[2-乙氧基-1-[[2'-(1H-四氮唑基-5)联苯基-4]甲基]-1H-苯并咪唑-7]
  • 坎地沙坦酯杂质 A
  • 坎地沙坦西酯
  • 坎地沙坦西酯杂质
  • 坎地沙坦酯 C11
  • 坎地沙坦酯(标准品)
  • 坎地沙坦酯(DMF)
  • 坎地沙坦酯(TCV-116)
  • 坎地沙坦酯, 一种ATR 拮抗剂
  • 坎地沙坦酯系统适用性(含杂质A、B、F )
  • 坎地沙坦酯峰鉴别
- 英文别名 -
  • Candesartan cilexetil
  • 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylate
  • 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
  • Cadesartan cilexetil
  • Candesartan Cilexeti
  • TCV-116
  • 2-Ethoxy-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester
  • TCV116
  • 2-ethoxy-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-Benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester
  • TCY 116
  • Atacand
  • Blopress
  • Candestartan
  • Candesartanciletexil
  • Candesantan Cilexetil
  • CANDESARTAN CILEXITIL
  • Amias
  • Parapres
  • Kenzen
  • TCV 116
  • Candesartan (Cilexetil)
  • CANDESARTAN CILEXTIL
  • candesartancilexetil
  • Candesartan cilexetil [USAN]
  • C33H34N6O6
  • 1H-Benzimidazolium, 7-carboxy-1-(2-((cyclohexylcarbonyl)oxy)ethyl)-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)-, hydroxide, inner salt, (+-)-
  • 2-Ethoxy-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycar
  • Candesartan Cilexetil
  • (+-)-1-Hydroxyethyl 2-ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester)
  • Spectrum_001707
  • CANDESARTAN CILEXETIL (MART.)
  • Candesartan cilexetil, United States Pharmacopeia (USP) Reference Standard
  • C2635
  • Candesartan cilexetil- Bio-X
  • CANDESARTAN CILEXETIL (USP MONOGRAPH)
  • H212/91
  • DTXCID50239
  • NSC758697
  • NS00006138
  • CANDESARTAN CILEXETIL [JAN]
  • Camptothecine, Antibiotic for Culture Media Use Only
  • 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylate
  • AB01274805_02
  • CANDESARTAN CILEXETIL [EP MONOGRAPH]
  • HMS1922J09
  • Candesartan cilexetil (Atacand)
  • L006257
  • KBio2_002187
  • (+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methylbenzimidazole-7-carboxylate
  • Spectrum2_000485
  • Candesartan 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester
  • Candesartan cilexetil for peak identification, European Pharmacopoeia (EP) Reference Standard
  • HMS3651I08
  • Atacand (TN)
  • C07709
  • CANDESARTAN CILEXETIL [MART.]
  • 1-(Cyclohexyloxycarbonyloxy)ethyl-2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazol-7-carboxylate
  • BCP9000480
  • 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-(ethyloxy)-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
  • 2-Ethoxy-3-[2''-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester
  • BRD-A65671304-001-02-6
  • AC-204
  • Candesartan 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester
  • SCHEMBL40831
  • 1261393-19-4
  • KBio2_004755
  • Ratacand
  • BCP22050
  • CHEMBL1014
  • Candesartan Cilexetil, Pharmaceutical Secondary Standard
  • Certified Reference Material
  • BSPBio_002691
  • D00626
  • KBioSS_002187
  • NCGC00095123-01
  • BDBM50318907
  • 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester, (+-)-
  • BC164274
  • NCGC00095123-16
  • SW220041-1
  • 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
  • 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
  • CANDESARTAN CILEXETIL [VANDF]
  • DS-1302
  • AB01274805_03
  • SY051248
  • AKOS015894954
  • Z1515383338
  • KBio2_007323
  • R85M2X0D68
  • SBI-0206767.P001
  • Candesartan cilexetil (JP17/USP)
  • AM90293
  • SPECTRUM1504261
  • AB01274805-01
  • AKOS015920180
  • 1H-BENZIMIDAZOLE-7-CARBOXYLIC ACID, 2-ETHOXY-1-((2'-(1H-TETRAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)METHYL)-, 1-(((CYCLOHEXYLOXY)CARBONYL)OXY)ETHYL ESTER, (+/-)-
  • SR-05000001976-1
  • Spectrum4_001124
  • DTXSID5020239
  • s2037
  • 145040-37-5
  • 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1h-benzimidazole-7-carboxylate
  • NCGC00095123-05
  • 2-Ethoxy-3-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester
  • CANDESARTAN CILEXETIL [USP-RS]
  • SMR003500784
  • SPBio_000349
  • Candesartan cilexetil, European Pharmacopoeia (EP) Reference Standard
  • 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester
  • HY-17505
  • SR-05000001976
  • 2-ETHOXY-1-[[2'-(2H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-1H-BENZIMIDAZOLE-7-CARBOXYLIC ACID 1-[[(CYCLOHEXYLOXY)CARBONYL]OXY]ETHYL ESTER
  • AB07617
  • CANDESARTAN 1-(((CYCLOHEXYLOXY)CARBONYL)OXY)ETHYL ESTER [MI]
  • Pharmakon1600-01504261
  • BRD-A65671304-001-03-4
  • NCGC00095123-10
  • EN300-118698
  • Candesartan cilexetil for system suitability, European Pharmacopoeia (EP) Reference Standard
  • (+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methylbenzimidazole-7-carboxylate
  • MLS004774127
  • KBio3_001911
  • Candesartan Celexetil Ester
  • CCG-39530
  • Q-200786
  • NSC-758697
  • NCGC00255218-01
  • UNII-R85M2X0D68
  • KS-1147
  • CANDESARTAN CILEXETIL (USP-RS)
  • CANDESARTAN CILEXETIL (EP MONOGRAPH)
  • candesartan cilexitil
  • HMS2093E20
  • DB00796
  • 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl] methyl]benzimidazole-4-carboxylate
  • GTPL8352
  • 1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate
  • MFCD00871371
  • Candesartan cilexetil , 97%
  • Candesartan hexetil
  • GHOSNRCGJFBJIB-UHFFFAOYSA-N
  • NSC 758697
  • CANDESARTAN CILEXETIL [USP MONOGRAPH]
  • CANDESARTAN CILEXETIL [ORANGE BOOK]
  • Tox21_302202
  • (+/-)-1-HYDROXYETHYL 2-ETHOXY-1-(P-(O-1H-TETRAZOL-5-YLPHENYL)BENZYL)-7-BENZIMIDAZOLECARBOXYLATE, CYCLOHEXYL CARBONATE (ESTER)
  • 2-ethoxy-3-[2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3h-benzoimidazole-4-carboxylic acid 1-cyclohe
  • NCGC00095123-02
  • Racanda
  • KBioGR_001607
  • NCGC00095123-03
  • Spectrum3_000996
  • FT-0602914
  • CANDESARTAN CILEXETIL [WHO-DD]
  • CCG-222334
  • 1-(cyclohexyloxycarbonyloxy)ethyl 1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
  • Candesartan Cilexetil-d11
  • Candesartan cilexetil, >=98% (HPLC)
  • (+/-)1-HYDROXYETHYL 2-ETHOXY-1-(P-(O-1H-TETRAZOL-5-YLPHENYL)BENZYL)-7-BENZIMIDAZOLECARBOXYLATE, CYCLOHEXYL CARBONATE (ESTER)
  • 1-(((cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
  • CHEBI:3348
  • Spectrum5_001462
  • CAS-145040-37-5
  • Q27075664
  • Candesartan cilexetil for system suitability
  • Candesartan cilexetil for peak identification
物化性质
实验特性
LogP 6.31910
PSA 143.34000
Merck 1739
折射率 1.665
沸点 843.3°C at 760 mmHg
熔点 157.0 to 163.0 deg-C
闪点 463.8±37.1 °C
溶解度 DMSO: ≥15mg/mL
颜色与性状 Powder
溶解性 DMSO: ≥15mg/mL
敏感性 对热敏感
最大波长(λmax) 304(EtOH)(lit.)
密度 1.4±0.1 g/cm3
计算特性
精确分子量 610.25400
氢键供体数量 1
氢键受体数量 10
可旋转化学键数量 13
同位素质量 610.254
重原子数量 45
复杂度 962
同位素原子数量 0
确定原子立构中心数量 0
不确定原子立构中心数量 1
确定化学键立构中心数量 0
不确定化学键立构中心数量 0
共价键单元数量 1
疏水参数计算参考值(XlogP) 7
拓扑分子极性表面积 143
海关数据
海关编码 2933990090
海关数据

中国海关编码:

2933990090

概述:

2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

申报要素:

品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期

Summary:

2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

生产方法和用途
用途 坎地沙坦酯作用与新型非肽类长效ATII受体拮抗剂,适用于高血压的治疗。
相关文献
专业数据库参考
PubChemId 2540
参考资料
Reaxys RN 7328188
Beilstein MFCD00871371
化合物详情(旧版)

物理化学性质

产品用途

用途:农药和医药中间体

应用领域







化学品安全说明书(MSDS)



储运特性





产品用途
用途:农药和医药中间体
坎地沙坦酯推荐生产厂家
960化工网为您提供坎地沙坦酯专业化合物百科信息,包括中文名,英文名,分子式,分子量,以及该化合物的CasNo.:145040-37-5,和相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等;| WAP 版:145040-37-5
平台客服 平台客服

平台在线客服